Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
ESMO Open
|
September 10, 2024
Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing
D Triner, R P Graf, R W Madison, et al.
Scientific Reports
|
November 10, 2020
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Alexander B Zaslavsky, M P Adams, X Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma
G Gakis, T M Morgan, S Daneshmand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2016
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches
A M Udager, T-Y Liu, S L Skala, et al.
The Journal of Urology
|
November 6, 2020
Reply by Authors
J M Schenk, L F Newcomb, Y Zheng, et al.
European Urology Focus
|
February 19, 2022
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]
Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
European Urology Focus
|
August 11, 2020
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium
Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
World Journal of Urology
|
June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
N Vasdev, H Zargar, J P Noël, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
ESMO Open
|
September 10, 2024
Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testing
D Triner, R P Graf, R W Madison, et al.
Scientific Reports
|
November 10, 2020
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Alexander B Zaslavsky, M P Adams, X Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2015
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma
G Gakis, T M Morgan, S Daneshmand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2016
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches
A M Udager, T-Y Liu, S L Skala, et al.
The Journal of Urology
|
November 6, 2020
Reply by Authors
J M Schenk, L F Newcomb, Y Zheng, et al.
European Urology Focus
|
February 19, 2022
Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54]
Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
European Urology Focus
|
August 11, 2020
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium
Maria Carmen Mir, Michele Marchioni, Homi Zargar, et al.
World Journal of Urology
|
June 9, 2018
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
N Vasdev, H Zargar, J P Noël, et al.
Page
of 9